Impact of vitamin D deficiency on the clinical presentation and prognosis of patients with newly diagnosed multiple myeloma

American Journal of Hematology

Volumn 84, Issue 7, 2009, Pages 397-400

  Ng, Alvin C ^a   Kumar, Shaji K ^a   Rajkumar, S Vincent ^a   Drake, Matthew T ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; SERUM ALBUMIN;

ADULT; ARTICLE; BONE DISEASE; CANCER STAGING; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTIPLE MYELOMA; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

C-REACTIVE PROTEIN; COHORT STUDIES; CREATININE; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; NEOPLASM STAGING; PREVALENCE; PROGNOSIS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 67649697320     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21412     Document Type: Article

References (23)

1. Roodman GD. Mechanisms of bone metastasis. N Engl J Med 2004; 350:1655-1664. (Pubitemid 38501167)
2. Roodman GD. New potential targets for treating myeloma bone disease. Clin Cancer Res 2006;12:6270s-6273s. (Pubitemid 44703801)
3. Holick MF. Vitamin D deficiency. N Engl J Med 2007;357:266-281.
4. Bikle D. Nonclassic actions of vitamin d. J Clin Endocrinol Metab 2009;94:26-34.
5. Park WH, Seol JG, Kim ES, et al. The induction of apoptosis by a combined 1,25(OH)2D3 analog, EB1089 and TGF-beta1 in NCI-H929 multiple myeloma cells. Int J Oncol 2002;20:533-542.
6. Park WH, Seol JG, Kim ES, et al. Induction of apoptosis by vitamin D3 analogue EB1089 in NCI-H929 myeloma cells via activation of caspase 3 and p38 MAP kinase. Br J Haematol 2000;109:576-583. (Pubitemid 30415185)
7. Park WH, Seol JG, Kim ES, et al. Cell cycle arrest induced by the vitamin D(3) analog EB1089 in NCI-H929 myeloma cells is associated with induction of the cyclin-dependent kinase inhibitor p27. Exp Cell Res 2000;254:279-286.
8. Kumagai T, O'Kelly J, Said JW, Koeffler HP. Vitamin D2 analog 19-nor-1,25- dihydroxyvitamin D2: Antitumor activity against leukemia, myeloma, and colon cancer cells. J Natl Cancer Inst 2003;95:896-905. (Pubitemid 36833881)
9. Holick MF, Chen TC. Vitamin D deficiency: A worldwide problem with health consequences. Am J Clin Nutr 2008;87:1080S-1086S. (Pubitemid 351549267)
10. Greipp PR, San Miguel J, Durie BG, et al. International staging system for multiple myeloma. J Clin Oncol 2005;23:3412-3420. (Pubitemid 46243484)
11. Yetley EA. Assessing the vitamin D status of the US population. Am J Clin Nutr 2008;88:558S-564S.
12. Holick MF. Vitamin D: A D-Lightful health perspective. Nutr Rev 2008;66: S182-S194.
13. Badros A, Goloubeva O, Terpos E, et al. Prevalence and significance of vitamin D deficiency in multiple myeloma patients. Br J Haematol 2008;142:492-494. (Pubitemid 351962187)
14. Barlogie B, Jagannath S, Desikan KR, et al. Total therapy with tandem transplants for newly diagnosed multiple myeloma. Blood 1999;93:55-65. (Pubitemid 29019388)
15. Vesole DH, Tricot G, Jagannath S, et al. Autotransplants in multiple myeloma: What have we learned? Blood 1996;88:838-847.
16. Kyle RA, Gertz MA, Witzig TE, et al. Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc 2003;78:21-33. (Pubitemid 36033957)
17. Timms PM, Mannan N, Hitman GA, et al. Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: Mechanisms for inflammatory damage in chronic disorders? QJM 2002;95:787-796.
18. Van den Berghe G, Van Roosbroeck D, Vanhove P, et al. Bone turnover in prolonged critical illness: Effect of vitamin D. J Clin Endocrinol Metab 2003;88:4623-4632. (Pubitemid 37357503)
19. Binkley N, Krueger D, Gemar D, Drezner MK. Correlation among 25-hydroxyvitamin D assays. J Clin Endocrinol Metab 2008;93:1804-1808.
20. Singh RJ, Taylor RL, Reddy GS, Grebe SK. C-3 epimers can account for a significant proportion of total circulating 25-hydroxyvitamin D in infants, complicating accurate measurement and interpretation of vitamin D status. J Clin Endocrinol Metab 2006;91:3055-3061. (Pubitemid 44271755)
21. Kao PC, Heser DW. Simultaneous determination of 25-hydroxy- and 1,25- dihydroxyvitamin D from a single sample by dual-cartridge extraction. Clin Chem 1984;30:56-61. (Pubitemid 14222560)
22. Bischoff-Ferrari HA, Giovannucci E, Willett WC, et al. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006;84:18-28. (Pubitemid 44699167)
23. Snozek CLH, Katzmann JA, Kyle RA, et al. Prognostic value of the serum free light chain ratio in newly diagnosed myeloma: Proposed incorporation into the international staging system. 2008;22:1933-1937.